Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/2003
06/18/2003EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors
06/18/2003EP1318995A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
06/18/2003EP1318991A1 Benzoic acid derivatives and uses thereof
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003EP1318836A2 Treatment of hyperproliferative diseases
06/18/2003EP1318835A1 Use of imidazoquinolinamines as adjuvants in dna vaccination
06/18/2003EP1318834A2 Compositions comprising mixtures of human cytokines and methods of producing the same
06/18/2003EP1318828A1 Orally administered peptides to ameliorate atherosclerosis
06/18/2003EP1318827A1 Polymer-modified synthetic proteins
06/18/2003EP1318823A1 Immunomodulatory preparation
06/18/2003EP1318817A1 Use of arginine in the preparation of a medicament for the prevention and treatment of the side effects associated with the intravenous administration of pharmaceuticals
06/18/2003EP1318814A2 Triazole compounds useful as protein kinase inhibitors
06/18/2003EP1318812A1 Methods for delaying recurrence of herpes virus symptoms
06/18/2003EP1318810A1 Manzamines for treatment of drug resistant infection
06/18/2003EP1318807A1 Photosensitizing ointment
06/18/2003EP1318806A1 Fatty acid synthase inhibitors
06/18/2003EP1318803A1 Fatty acid synthase inhibitors
06/18/2003EP1225898B1 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum
06/18/2003EP1171578B1 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof
06/18/2003EP1135401B1 Glyceryl nucleotides, method for the production thereof and their use
06/18/2003EP1077984B1 2"-deoxy hygromycin derivatives
06/18/2003EP0827498B1 New antiviral substituted pyrimidinedione homocarbocyclic nucleoside derivatives and methods for the preparation thereof and compositions containing the same as active ingredients
06/18/2003EP0538404B1 Fibroblast growth factor receptors
06/18/2003CN1425073A 病毒株 Strains
06/18/2003CN1425072A Gene therapy of HIV-positive patients by the expression of membrane-anchored gp41 peptides
06/18/2003CN1425027A HCV non-structural polypeptide
06/18/2003CN1425026A Cyclic hexapeptide derivatives
06/18/2003CN1425025A Daptomycin analogs as antibacterial agents
06/18/2003CN1425021A Gallotannins and ellagitannins as regulators of cytokine release
06/18/2003CN1425015A Chlorophyll and bacteriochlorophyll esters, and their preparation
06/18/2003CN1425010A Cyclic compound
06/18/2003CN1425009A Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
06/18/2003CN1425008A 3-aminoquinazolin-2, 4-dione antibacterial agents
06/18/2003CN1424926A Synergistic inhibition of viral replication long-chain hydrocarbons and nucleoside analogs
06/18/2003CN1424917A Recombinant envelope vaccine against flavivirus infection
06/18/2003CN1424913A Antivirus medicine
06/18/2003CN1424910A IL-8 receptor antagonists
06/18/2003CN1424907A Improved pharmaceutical formulations
06/18/2003CN1424320A Hemsleyadine derivative and its preparing method and use as bactericidal agent
06/18/2003CN1424317A Structure and preparation of rhamnegin with xylopyranose branched chain as medicine
06/18/2003CN1424312A Specific indole compound and its preparation and use in treating and preventing cancers
06/18/2003CN1424110A Vaccine adjuvant against hepatitis B
06/18/2003CN1424105A Medicinal spray
06/18/2003CN1424099A Medicines for treating hepatitis B and preparation thereof
06/18/2003CN1424098A Medicines for treating pulmonary tuberculosis
06/18/2003CN1424079A Medicine for summer damp catch-cold and its preparing method
06/18/2003CN1424078A Medicine for acute pulmonary infection and its preparing method
06/18/2003CN1424059A Chinese medicine for treating liver illness
06/18/2003CN1424052A Medicine for treating chronic hepatitis B
06/18/2003CN1424048A Medicine for treating bacillary dysentery and enteritis
06/18/2003CN1424040A Medicine against human papilloma virus
06/18/2003CN1424039A Drug composition containing cefazolin and beta-lactamase inhibitor
06/18/2003CN1424036A Powder-injections of cyclonorfloxacin and its salts and their preparation
06/18/2003CN1111540C Tandem synthetic HIV-1 peptides
06/18/2003CN1111531C Process for preparing 6-0-monoesters of castanospermine
06/18/2003CN1111429C Urease-based vaccine against HeIicobacter infection
06/18/2003CN1111411C Antibacterial clindamycin phosphate powder injection and its preparing process
06/18/2003CN1111410C Process for preparation of pharmaceutical composition
06/18/2003CN1111357C Food products having enhanced cocoa polyphenol content and processes for producing same
06/17/2003US6579989 Sulphostin analogue and process for producing sulphostin and its analogue
06/17/2003US6579981 Treating herpes virus
06/17/2003US6579978 Biomaterials comprising N-sulphated hyaluronic acid compounds or derivatives thereof
06/17/2003US6579970 Specific octapeptides, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds and immune effector cells raised in response to presentation of these epitopes.
06/17/2003US6579902 Antibiotic; ethoxy-carbamic acid 3'-ester of N-(7-((6-deoxy-5-C-methyl-4-O- methyl-alpha-L-lyxo-hexopyranosyl)oxy)-4-hydroxy-8-methyl-2-oxo-2H-1 -benzopyran-3-yl)-benzeneacetamide
06/17/2003US6579894 Bactericides, fungicides
06/17/2003US6579877 Combination of benzoquinazoline antifolates and protecting agents
06/17/2003US6579874 Substituted azoles
06/17/2003US6579872 Bezamide derivatives for the treatment of diseases mediated by cytokines
06/17/2003US6579695 Phosphopantetheinyl transferases and uses thereof
06/17/2003US6579533 Bioabsorbable drug delivery system for local treatment and prevention of infections
06/17/2003US6579528 Vaccines; genetically engineering
06/17/2003US6579526 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
06/17/2003US6579521 Methods of therapy for HIV infection
06/17/2003CA2251928C Antifungal compositions
06/17/2003CA2232410C Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines
06/17/2003CA2118816C Composition for introducing nucleic acid complexes into higher eucaryotic cells
06/17/2003CA2118114C Potentiation of antimicrobial effects
06/17/2003CA2078605C Chicken anaemia agent vaccine
06/14/2003CA2364985A1 Imidazo(2,1-b)thiadiazole sulfonamides
06/13/2003WO2003047602A1 Immunostimulatory oligodeoxynucleotides
06/13/2003CA2452909A1 Immunostimulatory oligodeoxynucleotides
06/12/2003WO2003049117A2 Immune globulin formulations for the treatment and prevention of an orthopoxvirus infection
06/12/2003WO2003048781A1 Uses of the glycine-n-acyl transferase (gnat) for the diagnosis and therapy of inflammatory diseases and sepsis
06/12/2003WO2003048780A2 Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis
06/12/2003WO2003048390A1 A process for the preparation of a non-toxic anthrax vaccine
06/12/2003WO2003048383A2 Effectors of innate immunity
06/12/2003WO2003048380A1 Method of screening forpotential anti-bacterial agents
06/12/2003WO2003048379A1 T-bet compositions and methods of use thereof
06/12/2003WO2003048375A1 Hybrid glycosylated products and their production and use
06/12/2003WO2003048371A2 Dna vaccine
06/12/2003WO2003048349A2 Acetoacetyl-coa thiolase and use of for the identification of novel fungicidal substances
06/12/2003WO2003048337A2 Antibody to latent membrane proteins and uses thereof
06/12/2003WO2003048205A2 Novel proteins with il-6 inhibiting activity
06/12/2003WO2003048201A1 Antimicrobial bolisin peptides
06/12/2003WO2003048197A1 Production and of viruses, viral isolates and vaccines
06/12/2003WO2003048187A2 Peptides and use thereof in therapeutic agents against hiv infection
06/12/2003WO2003048186A2 Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens
06/12/2003WO2003048184A2 Flavivirus ns1 subunit vaccine
06/12/2003WO2003048160A1 Ring fused pyrazole derivatives
06/12/2003WO2003048156A1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine
1 ... 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 ... 1798